A Study to Assess the Response Rate of PROCRIT (Epoetin Alfa) Given at a Dose of 40,000 Units Once a Week to Cancer Patients With Anemia Who Are Not Receiving Chemotherapy.
Clinical trial NCT00350090 · TERMINATED
Trial details
- NCT number
- NCT00350090
- Sponsor
- Ortho Biotech Products, L.P.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2002-09-01
- Enrollment
- 98
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.